Change at top for Mass.-based Biogen after Alzheimer's drug flops
Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer's drug less than a year after the medication's launch triggered backlash.
Source: wcvb.com
Stay updated with breaking news from Aduhelm For. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer's drug less than a year after the medication's launch triggered backlash.